While our findings elucidate the specific function of PTBP1 in HCC and identify a crucial AS target, MAPT, which demonstrates a strong association with the initiation and progression of HCC and patient prognosis, further investigation is necessary to elucidate MAPT’s function in vivo. This evidence concerns the gene MAPT and hepatocellular carcinoma.